Search

18 Aug 2022: With themes of Content, Collections and Community, Creative Impact, and Creative Innovation, the day featured great speakers, inspirational panels, demos, pitches and of course conversation designed to spark new ideas and ... More on Creative Cambridge.

9 May 2022: KARPAS 417 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge.

15 Mar 2022: Impact Insight video case study: Versed AI. The second in our new series of Impact Insight videos focuses on Versed AI. ... Whether you’re a University researcher or academic with a novel idea or technology, an investor keen to support innovations

18 Jul 2022: Related news and case studies. Pause. Play. Review our answers to your most frequently asked questions.

16 Mar 2022: Share:. New grafting technique could combat the disease threatening Cavendish bananas. ... Grafting genetically different root and shoot tissues can result in a plant with new traits – ranging from dwarf shoots, to pest and disease resistance.

12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Versed AI. Share:. Impact Insight video case study: Versed AI. The second in our Impact Insight video series focuses on Versed AI. It tells the story behind the creation

15 Dec 2022: Market-based solutions comprise many arrangements, such as licensing innovative tools, creating new companies (including social ventures), carrying out consultancies, and bringing. ... The above reduces the possibilities that usually originate from

9 May 2022: KARPAS 929 Human Myeloma cell line, developed at the University of Cambridge, useful in oncology research.

23 Mar 2022: Whether you’re a University researcher or academic with a novel idea or technology, an investor keen to support innovations emerging from the University, or an external organisation looking for new

15 Feb 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Watch our #nextgreatidea film. Share:. Our film is a distinctive take on innovation that showcases some of the world-changing ideas we have supported in the journey to market – from a

10 May 2022: Here are some ideas:. Performance/applications data. Prototype development, scale-up of process, develop new applications. ... parties. Example of a benefit statement. We can help primary school teachers teach children to speak a new language more

2 Feb 2022: £1.5m investment via Crowdcube and Cambridge Enterprise creates new jobs and further development of the tech.

9 May 2022: KARPAS 707H Human myeloma cell line suitable for the generation of stable human hybridomas for the creation of fully human monoclonal antibodies.

11 Apr 2022: A new class of battery technology. Nyobolt’s team of experts has pioneered a new class of battery technology that achieves record-breaking ultra-fast charging.

23 Nov 2022: a foothold on the ground, who could go in and do preliminary consultations to grasp whether the communities could be interested or not in trying something new.

27 Sep 2022: Early stage innovations are licensed to existing companies for development or spun out as new companies. ... Among these were three companies developing new technologies focused on reducing carbon emissions—and Carbon Re.

9 May 2022: KARPAS 1272 Human Myeloma cell line, useful in oncology research, developed at the University of Cambridge.

12 Oct 2022: Chris Gibbs shares his perspectives on the importance of sustainability, investing in sustainability businesses and building entrepreneurial mindsets through the Carbon Challenge.

15 Mar 2022: Impact Insight video case study: Kalamna toolkit. The third in our new series of Impact Insight videos focuses on the licensing of the Kalamna toolkit for learning Arabic. ... Dr Khalil has spent her career researching how young Arabic learners can be

18 Aug 2022: with the potential to provide tens of thousands of new jobs over the next few years.

9 May 2022: KARPAS 241 Human Monoblastic cell line useful in oncology research, developed at the University of Cambridge.

11 Apr 2022: Over the past year, the team has identified and reviewed 55 new opportunities and presented 13 to the Ceres Investment Committee.

9 May 2022: COBRAS Concrete Bridge Assessment Program is a yield-line analysis software for assessing the ultimate load capacity of concrete structures.

19 Sep 2022: We are excited to pioneer a new era in the treatment of diseases related to mitochondrial dysfunction. ... The expertise we have assembled and the platform technologies we have created will allow new inroads into treating both rare genetic diseases as

11 Apr 2022: New Zealand Family Cancer Services. BOADICEA being incorporated within BRRISK helps time-poor GP’s to stratify patients according to risk. ... Oncoplastic Breast Surgeon, Auckland, New Zealand. Pause. Play. If you would like more information on BOADICEA

9 May 2022: Questionnaire developed at the University of Cambridge and validated for use with reception- and nursery-aged children.

4 Oct 2022: The finalists’ pitches will be judged on a number of criteria, including each business’s competitive position, the potential for new business creation, and each team’s collective skill set.

11 Apr 2022: Evidence included scientific papers, government reports, and local news articles. The close collaboration with local expert teams throughout the process brought great depth of knowledge, and ensured that visions remained focused

9 May 2022: Hybridoma cell line producing YTH 53.1 antibodies raised against human CD59 which are rat monoclonal antibodies of the IgG2b isotype.

11 Nov 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 11 November 2022. Sparxell wins the 2022 Chris Abell Postdoc Business Plan Competition. Share:. Sparxell has won the Chris Abell Postdoc Business Plan Competition 2022, securing the £20

9 May 2022: Hybridoma cell line producing YTH 30.15 antibodies raised against human CD7 which are rat monoclonal antibodies of the IgG2b isotype.

11 Apr 2022: HappyShield provides a barrier from splashes and sprays of infected bodily fluids and can be cleaned and reused indefinitely.

17 Aug 2022: In addition, applicants will benefit from even more support with our new summer programme, which offers an additional series of activities through a blend of round table discussions, one-to-one

9 May 2022: Hybridoma cell line producing YTH 24.5 antibodies raised against human CD45 which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing YTH 81.5 antibodies raised against human CD11a which are rat monoclonal antibodies of the IgG2a isotype.

11 Apr 2022: so-called Valley of Death, the interval when promising new research can wither and die for lack of funding. ... Next steps. Apollo is now advancing into clinical development as well as identifying new programmes.

9 May 2022: Hybridoma cell line producing YFC 120.5 antibodies raised against human CD16 which are rat monoclonal antibodies of the IgG2b isotype.

12 Apr 2022: University of Cambridge spin-out RegGenome announces the completion of a $6 million seed funding round.

11 Apr 2022: We ran a knowledge exchange programme on research commercialisation for three southern African universities in 2019.

9 May 2022: CHO cells transfected to express human FcgRlla allotype 131R as a transmembrane protein with its native intracellular domain.

28 Apr 2022: and Macmillan Cancer Support, in order to define a new clinical pathway for treating suspected neutropenic sepsis, and to ensure people living with disease continue to be at the heart of

11 Apr 2022: investment. Less than five years later, we again released news about the company. ... This time, however, the news was the completion of a $9.5 million Series A funding round.

9 May 2022: CHO cells transfected to express human FcgRlla allotype 131H as a transmembrane protein with its native intracellular domain.

23 Mar 2022: Insights from Tenyks help engineers accelerate their development lifecycle, so they spend less time onboarding new users, reducing customer acquisition costs, and boosting the accuracy of AI. ... Moreover, future new deployments can be onboarded in half

9 May 2022: Hybridoma cell line producing YTH 54.12 antibodies raised against human CD45 which are rat monoclonal antibodies of the IgG2b isotype.

14 Jun 2022: Share:. Spirea Limited, a University of Cambridge spin-out company created to advance a new generation of antibody drug conjugate (ADC) therapeutics, has secured funding of £2.4 million. ... We welcome our new investors and thank our existing investors

9 May 2022: CHO cells transfected to express human FcgRllb allotype 131R as a transmembrane protein with its native intracellular domain.

22 Mar 2022: When Cambridge Enterprise was looking to make a film about Consultancy Services, Dr Hugh Hunt, Cambridge University Reader in Engineering Dynamics and...

8 Mar 2022: Even in new construction, it is important to ensure safe environments and understand the short- and long-term environmental impact of a site. ... The proliferation of new sensors and satellite technology has the potential to fuel a revolution in

9 May 2022: Hybridoma cell line producing YFC118.12 antibodies raised against human CD18 which are rat monoclonal antibodies of the IgG2b isotype.